Follow-up of primary melanoma patients with high risk of recurrence: recommendations based on evidence and consensus

• Published in: Clinical & translational oncology Vol. 24; no. 8; pp. 1515 - 1523
• Main Authors: Campos-Balea, Begoña, Fernández-Calvo, Ovidio, García-Figueiras, Roberto, Neira, Carlos, Peña-Penabad, Carmen, Rodríguez-López, Carmela, Vílchez-Simo, Rocío, Quindós-Varela, María
• Format: Journal Article
• Language: English
• Published: Cham Springer International Publishing 01-08-2022
• Subjects: Medicine; Medicine & Public Health; Oncology; Review Article; Risk of recurrence; Surveillance; Imaging; Prognostic factors; Melanoma; Follow-up
• ISSN: 1699-3055; 1699-3055
• DOI: 10.1007/s12094-022-02822-x

In spite of the good prognosis of patients with early-stage melanoma, there is a substantial proportion of them that develop local or distant relapses. With the introduction of targeted and immune therapies for advanced melanoma, including at the adjuvant setting, early detection of recurrent melanoma and/or second primary lesions is crucial to improve clinical outcomes. However, there is a lack of universal guidelines regarding both frequency of surveillance visits and diagnostic imaging and/or laboratory evaluations. In this article, a multidisciplinary expert panel recommends, after careful review of relevant data in the field, a consensus- and experience-based follow-up strategy for melanoma patients, taking into account prognostic factors and biomarkers and the high-risk periods and patterns of recurrence in each (sub) stage of the disease. Apart from the surveillance intensity, healthcare professionals should focus on patients’ education to perform regular self-examinations of the skin and palpation of lymph nodes.